<html xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:st1="urn:schemas-microsoft-com:office:smarttags" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<META HTTP-EQUIV="Content-Type" CONTENT="text/html; charset=us-ascii">
<meta name=Generator content="Microsoft Word 11 (filtered medium)">
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
name="State"/>
<o:SmartTagType namespaceuri="urn:schemas-microsoft-com:office:smarttags"
name="place"/>
<!--[if !mso]>
<style id=owaTempEditStyle>
st1\:*{behavior:url(#default#ieooui) }
</style>
<![endif]-->
<style>
<!--
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman";}
a:link, span.MsoHyperlink
{color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{color:purple;
text-decoration:underline;}
p
{margin:0in;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman";}
span.emailstyle17
{font-family:Arial;
color:windowtext;}
span.EmailStyle19
{mso-style-type:personal-reply;
font-family:Arial;
color:navy;}
@page Section1
{size:8.5in 11.0in;
margin:1.0in 1.25in 1.0in 1.25in;}
div.Section1
{page:Section1;}
-->
</style>
<meta name="SKYPE_FRAMEID" content=EXJEGPQBGI>
<meta id="skype_v3_tb_marker_id" name="SKYPE_PARSING_HAS_FINISHED"
content=metacontent>
</head>
<body lang=EN-US link=blue vlink=purple ocsi=x>
<div class=Section1>
<div>
<div>
<div>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 color=black face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:black'>Many of us have run across a number of
difficulties in attempting to provide a consumer-friendly unused medicine
disposal process. There have been instances of individuals using this context
to engage in frankly illegal acts and have been prosecuted. That makes it
difficult for those attempting to follow the rules and regulations that are in
existence today as increased scrutiny, fear, or hesitation makes engaging
others perhaps more difficult. It is good news on the one hand that the White
House Office of National Drug Control Policy points to the explicit need for
more drug return programs, yet there will be those who take advantage of those
who do not know better and create programs or situations that will interfere
with the progress we all are trying to make.</span></font><font color=black><span
style='color:black'><o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
<p class=MsoNormal><st1:place w:st="on"><st1:State w:st="on"><font size=2
color=black face=Arial><span style='font-size:10.0pt;font-family:Arial;
color:black'>Maine</span></font></st1:State></st1:place><font size=2
color=black face=Arial><span style='font-size:10.0pt;font-family:Arial;
color:black'> has a mailback pilot test </span></font><font size=2 face=Arial><span
style='font-size:10.0pt;font-family:Arial'>program which does indeed take
controlled drugs, but is NOT a<font color=black><span style='color:black'>
permanent sustainably funded program. </span></font><font color=navy><span
style='color:navy'><o:p></o:p></span></font></span></font></p>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'><o:p> </o:p></span></font></p>
<p class=MsoNormal><font size=2 color=black face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:black'>It </span></font><font size=2 face=Arial><span
style='font-size:10.0pt;font-family:Arial'>is solely a proof<font color=black><span
style='color:black'> of concept test. </span></font><font color=navy><span
style='color:navy'><o:p></o:p></span></font></span></font></p>
<p class=MsoNormal><font size=2 color=navy face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:navy'><o:p> </o:p></span></font></p>
<p class=MsoNormal><font size=2 color=black face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:black'>We believe it has been successful and
replicable when the proper legislation can be enacted to enable such an
extension. It is our understanding that indeed that legislation is before
congress which will enable DEA to move forward toward perhaps multiple
different processes across the country which will at the same time not enable
industrial scale diversion of controlled drugs. I doubt anyone on this list
does not want the enabling legislation. </span></font><font color=black><span
style='color:black'><o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 color=black face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:black'>However recently it has come to our
attention that a mailback is being promoted across the country. Those of us in <st1:State
w:st="on"><st1:place w:st="on">Maine</st1:place></st1:State> believe it can be
misconstrued to legally accept controlled drugs which it cannot. We believe it
has misconstrued those pharmacies in <st1:State w:st="on"><st1:place w:st="on">Maine</st1:place></st1:State>
who have been part of our pilot as to not being able to accept controlled drugs
which is incorrect </span></font><font color=black><span style='color:black'><o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
<p class=MsoNormal><font size=2 color=black face=Arial><span style='font-size:
10.0pt;font-family:Arial;color:black'>We fear that if indeed this program
insists that they have the answer there will be less interest in attempting to
support the congressional action needed to facilitate the DEA. In short setting
us all back. If the organization </span></font><font size=2 face=Arial><span
style='font-size:10.0pt;font-family:Arial'>wishes to<font color=black><span
style='color:black'> help out, it seems to us they should engage their
community pharmacists in approaching congress and or their patients to assist
with resolving the problems. The simple undersized statement that “Some
limitations may apply” in the smallest </span></font>typeface on the web page
are not enough notice to indicate an awareness of the steep hill we have yet to
still climb. </span></font><o:p></o:p></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> </span></font><font color=navy><span
style='color:navy'><o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'>Stevan Gressitt, M.D., <o:p></o:p></span></font></p>
<p class=MsoNormal><font size=3 color=black face="Times New Roman"><span
style='font-size:12.0pt;color:black'> <o:p></o:p></span></font></p>
</div>
</div>
</div>
</div>
</body>
</html>